Table of Contents

Protocols for diagnosing myocardial infarction.
Troponin and other markers of necrosis for risk stratification in patients with acute coronary syndromes.
Challenges interpreting troponin values.
Natriuretic peptides and inflammatory markers for risk stratification in patients with ischemic heart disease.
Novel markers in patients with suspected acute coronary syndromes.
Use of natriuretic peptides in the diagnosis of heart failure.
Biomarkers for risk stratification in patients with heart failure.
Natriuretic peptides for disease monitoring in patients with chronic heart failure.
C-reactive protein.
Newer markers for population screening: focus on lipoprotein-related markers.
Moving towards personalized medicine.